Teva Comments On Mylan Paragraph IV Filing For COPAXONE(R); Files Lawsuit Against - Congoo

|

|

News

Media & Advertising

ONLINE BROKER

Teva Comments on Mylan Paragraph IV Filing for COPAXONE(R); Files Lawsuit against

Have an interest in this Story?
Sign Up for Real-Time email updates

Pharmacy Choice | November 08, 2009

- (NewsRx.com) Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) commented today on the abbreviated new drug application (ANDA) containing a Paragraph IV certification for COPAXONE (glatiramer acetate injection), filed by Mylan Pharmaceuticals Inc. Teva also announced that it has filed a lawsuit ag...

Read Full Article

Leave a Comment:

You must be logged in to leave a comment Log in | Register

Most Read World Articles

Pakistani duo held in Italy for links to 26/11 - The Hindu

UK PM visits scene of massive floods - Sky News Australia

31 dead, 82 trapped in China mine blast - Livemint.com

Obama abroad - Washington Post

Police Sergeant Accused of Misconduct - ABC 7

Featured Members

THENNY MEJIA
Sr. Vice President
Healthcare Industry

Leo Petrik
Founder & CEO
Entrepreneur

View more profiles

Access dozens of premium and subscriptions sites Free! Download now.

Advertise | Build a News Circle | Get News Briefings | Congoo News Home | Get the Netpass

About Congoo | Terms | Privacy | Need Help? | Site Map

Copyright ©2009 Congoo.com. All Rights Reserved.